Detectable serum tobramycin concentrations in a patient with renal dysfunction receiving tobramycin by inhalation

American Journal of Health-System Pharmacy

Volumn 68, Issue 15, 2011, Pages 1385-1386

  Langley, Alissa ^a   Cottingham, Lauren ^b  

^a Department of Pharmacy Services   (United States)

^b Saint Joseph Hospital Lexington   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TOBRAMYCIN;

AGED; ARTIFICIAL VENTILATION; BRAIN INJURY; BRAIN TUMOR; CASE REPORT; CHRONIC KIDNEY DISEASE; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; CRANIOTOMY; CYSTIC FIBROSIS; DRUG BLOOD LEVEL; DRUG MONITORING; DRUG WITHDRAWAL; HEART ARREST; HEART INFARCTION; HEMODIALYSIS; HOSPITALIZATION; HUMAN; KIDNEY DYSFUNCTION; LETTER; LUNG INFECTION; MALE; NEPHROTOXICITY; OTOTOXICITY; PATIENT MONITORING; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RESPIRATORY FAILURE; SUBDURAL HEMATOMA; TRACHEOTOMY;

EID: 79961106950     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp100683     Document Type: Letter

References (4)

1. Cooney GF, Lum BL, Tomaselli M et al. Absolute bioavailability and absorption characteristics of aerosolized tobramycin in adults with cystic fibrosis. J Clin Pharmacol. 1994; 34:255-9. (Pubitemid 24102095)
2. Cannella CA, Wilkinson ST. Acute renal failure associated with inhaled tobramycin. Am J Health-Syst Pharm. 2006; 63:1858-61. (Pubitemid 44477457)
3. Edson RS, Brey RH, McDonald TJ et al. Vestibular toxicity due to inhaled tobramycin in a patient with renal insufficiency. Mayo Clin Proc. 2004; 79:1185-91. (Pubitemid 39129483)
4. Izquierdo MJ, Gomez-Alamillo C, Ortiz F et al. Acute renal failure associated with use of inhaled tobramycin for treatment of chronic airway colonization with Pseudomonas aeruginosa. Clin Nephrol. 2006; 66:464-7. (Pubitemid 44896157)